1
|
The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation.
|
Oncology
|
2016
|
0.79
|
2
|
A case report--treatment of metastatic colorectal cancer in a patient on hemodialysis.
|
J Gastrointest Cancer
|
2014
|
0.76
|
3
|
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.
|
Oncology
|
2015
|
0.76
|
4
|
Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma.
|
Oncology
|
2015
|
0.75
|
5
|
Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively.
|
Oncology
|
2015
|
0.75
|
6
|
Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors.
|
Oncology
|
2016
|
0.75
|
7
|
Isotretinoin maintenance therapy for glioblastoma: a retrospective review.
|
J Oncol Pharm Pract
|
2013
|
0.75
|
8
|
Early versus Delayed Therapy of Advanced Gastric Cancer Patients--Does It Make a Difference?
|
Oncology
|
2015
|
0.75
|
9
|
Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies.
|
Oncology
|
2015
|
0.75
|
10
|
101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.
|
Oncology
|
2017
|
0.75
|
11
|
Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency.
|
Support Care Cancer
|
2014
|
0.75
|